Your browser doesn't support javascript.
loading
Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer.
Zhou, Yongheng; Qi, Wenqiang; Cui, Jianfeng; Zhong, Minglei; Lv, Guangda; Qu, Sifeng; Chen, Shouzhen; Li, Rongyang; Shi, Benkang; Zhu, Yaofeng.
Affiliation
  • Zhou Y; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Qi W; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Cui J; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Zhong M; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Lv G; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Qu S; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Chen S; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Li R; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
  • Shi B; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Zhu Y; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
Front Oncol ; 12: 911725, 2022.
Article in En | MEDLINE | ID: mdl-35903679
Background: With the widespread adoption of prostatic-specific antigen (PSA) screening, the detection rates of prostate cancer (PCa) have increased. Due to the low specificity and high false-positive rate of serum PSA levels, it was difficult to diagnose PCa accurately. To improve the diagnosis of PCa and clinically significant prostate cancer (CSPCa), we established novel models on the basis of the prostate health index (PHI) and multiparametric magnetic resonance imaging (mpMRI) in the Asian population. Methods: We retrospectively collected the clinical indicators of patients with TPSA at 4-20 ng/ml. Furthermore, mpMRI was performed using a 3.0-T scanner and reported in the Prostate Imaging Reporting and Data System version 2.1 (PI-RADS). Univariable and multivariable logistic analyses were performed to construct the models. The performance of different models based on PSA derivatives, PHI derivatives, PI-RADS, and a combination of PHI derivatives and PI-RADS was evaluated. Results: Among the 128 patients, 47 (36.72%) patients were diagnosed with CSPCa and 81 (63.28%) patients were diagnosed with non-CSPCa. Of the 81 (63.28%) patients, 8 (6.25%) patients were diagnosed with Gleason Grade 1 PCa and 73 (57.03%) patients were diagnosed with non-PCa. In the analysis of the receiver operator characteristic (ROC) curves in TPSA 4-20 ng/ml, the multivariable model for PCa was significantly larger than that for the model based on the PI-RADS (p = 0.004) and that for the model based on the PHI derivatives (p = 0.031) in diagnostic accuracy. The multivariable model for CSPCa was significantly larger than that for the model based on the PI-RADS (p = 0.003) and was non-significantly larger than that for the model based on the PHI derivatives (p = 0.061) in diagnostic accuracy. For PCa in TPSA 4-20 ng/ml, a multivariable model achieved the optimal diagnostic value at four levels of predictive variables. For CSPCa in TPSA 4-20 ng/ml, the multivariable model achieved the optimal diagnostic value at a sensitivity close to 90% and 80%. Conclusions: The models combining PHI derivatives and PI-RADS performed better in detecting PCa and CSPCa than the models based on either PHI or PI-RADS.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland